Study to Collect Safety Data and Efficacy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy with Nivolumab or Nivolumab-Ipilimumab Combination

被引：0
|
作者：
Rexer, H. [1 ]
Gruenwald, V. [2 ]
Bedke, J. [3 ]
机构：
[1] AUO Geschaftsstelle, Schwarz, Germany
[2] Univ Klinikum Essen, Essen, Germany
[3] Deutsch Krebsgesellschaft, Arbeitsgemeinschaft Urol Onkol, Organgrp Nierenzellkarzinom, Berlin, Germany
来源：
UROLOGE | 2020年 / 59卷 / 04期
关键词：
D O I：
10.1007/s00120-020-01166-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 523
页数：2
相关论文
共 50 条
  • [1] CaboCHECKStudie zur Erfassung von Sicherheitsdaten und Wirksamkeit bei der Behandlung des fortgeschrittenen Nierenzellkarzinoms nach Vortherapie mit Nivolumab oder Nivolumab-Ipilimumab-KombinationCaboCHECKStudy to collect safety data and efficacy in the treatment of advanced renal cell carcinoma after prior therapy with nivolumab or nivolumab-ipilimumab combination
    H. Rexer
    V. Grünwald
    J. Bedke
    Forum, 2020, 35 (3) : 244 - 245
  • [2] REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study
    Vauchier, Charles
    Auclin, Edouard
    Barthelemy, Philippe
    Carril-Ajuria, Lucia
    Ryckewaert, Thomas
    Borchiellini, Delphine
    Castel-Ajgal, Zahra
    Bennamoun, Mostefa
    Campedel, Luca
    Thiery-Vuillemin, Antoine
    Coquan, Elodie
    Crouzet, Laurence
    Berdah, Jean-Francois
    Chevreau, Christine
    Ratta, Raffaele
    Flechon, Aude
    Lefort, Felix
    Albiges, Laurence
    Gross-Goupil, Marine
    Vano, Yann-Alexandre
    Thibault, Constance
    Oudard, Stephane
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [3] Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma
    Gao, Xin
    McDermott, David F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 947 - 957
  • [4] Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma
    Ueda, Kosuke
    Ito, Naoki
    Sakai, Yuya
    Ohnishi, Satoshi
    Hirano, Taishi
    Kurose, Hirofumi
    Chikui, Katsuaki
    Uemura, Keiichiro
    Nishihara, Kiyoaki
    Nakiri, Makoto
    Suekane, Shigetaka
    Igawa, Tsukasa
    ANTICANCER RESEARCH, 2024, 44 (11) : 5087 - 5093
  • [5] The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma
    Ornstein, Moshe C.
    Rini, Brian I.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) : 577 - 584
  • [6] Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
    Hammers, Hans J.
    Plimack, Elizabeth R.
    Infante, Jeffrey R.
    Rini, Brian I.
    McDermott, David F.
    Lewis, Lionel D.
    Voss, Martin H.
    Sharma, Padmanee
    Pal, Sumanta K.
    Razak, Albiruni R. Abdul
    Kollmannsberger, Christian
    Heng, Daniel Y. C.
    Spratlin, Jennifer
    McHenry, M. Brent
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3851 - +
  • [7] Advanced Renal Cell Carcinoma: Combination of Nivolumab and Ipilimumab versus Sunitinib
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2019, 50 (02) : 136 - 136
  • [8] Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
    Iinuma, Koji
    Kameyama, Koji
    Kawada, Kei
    Fujimoto, Shota
    Takagi, Kimiaki
    Nagai, Shingo
    Ito, Hiroki
    Ishida, Takashi
    Kawase, Makoto
    Kawase, Kota
    Nakai, Chie
    Kato, Daiki
    Takai, Manabu
    Nakane, Keita
    Koie, Takuya
    CURRENT ONCOLOGY, 2021, 28 (02) : 1402 - 1411
  • [9] Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma
    Gupta, Mehul
    Stukalin, Igor
    Meyers, Daniel
    Goutam, Sid
    Heng, Daniel Y. C.
    Cheng, Tina
    Monzon, Jose
    Navani, Vishal
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319607
  • [10] Hypophysitis induced by ipilimumab and nivolumab combination therapy for advanced renal cell carcinoma: A case report
    Motonaga, Aoi
    Nakanishi, Shotaro
    Tanaka, Kei
    Nishida, Sho
    Izumi, Keiichiro
    Saito, Seiichi
    UROLOGY CASE REPORTS, 2021, 38
12345